Fust Matthew K

CIK 00013972665 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001397266

Recent Transactions

36 trades

Award
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2022-06-23+20,500→ 52,000 total
Award
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2022-06-23+20,500→ 52,000 total
Award
Atara Biotherapeutics, Inc.$ATRA
Non-Qualified Stock Option (Right to Buy)
2022-06-23+31,500→ 31,500 total
Award
Atara Biotherapeutics, Inc.$ATRA
Non-Qualified Stock Option (Right to Buy)
2022-06-23+31,500→ 31,500 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2021-07-19$19.50/sh−5,000→ 12,536 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2021-07-19$1.91/sh+5,000→ 17,536 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Non-qualified stock option (Right to Buy)
2021-07-19−5,000→ 32,092 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2021-07-19$19.50/sh−5,000→ 12,536 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2021-07-19$1.91/sh+5,000→ 17,536 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Non-qualified stock option (Right to Buy)
2021-07-19−5,000→ 32,092 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2021-06-24+4,125→ 4,125 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2021-06-24+2,145→ 15,695 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2021-06-24+4,125→ 4,125 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2021-06-24+2,145→ 15,695 total
Award
Atara Biotherapeutics, Inc.$ATRA
Non-Qualified Stock Option (Right to Buy)
2016-01-04+10,500→ 10,500 total
Award
Atara Biotherapeutics, Inc.$ATRA
Non-Qualified Stock Option (Right to Buy)
2016-01-04+10,500→ 10,500 total
Sale
ONYX PHARMACEUTICALS INC
Common Stock
2011-11-18$38.05/sh−867→ 45,310 total
Sale
ONYX PHARMACEUTICALS INC
Common Stock
2011-11-18$38.05/sh−867→ 45,310 total
Sale
ONYX PHARMACEUTICALS INC
Common Stock
2011-04-01$35.02/sh−800→ 45,801 total
Sale
ONYX PHARMACEUTICALS INC
Common Stock
2011-04-01$35.02/sh−800→ 45,801 total
Award
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
2011-03-31+42,000→ 42,000 total
Award
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
2011-03-31+42,000→ 42,000 total
Award
ONYX PHARMACEUTICALS INC
Common Stock
2011-03-31+22,500→ 46,601 total
Award
ONYX PHARMACEUTICALS INC
Common Stock
2011-03-31+6,000→ 24,101 total
Award
ONYX PHARMACEUTICALS INC
Common Stock
2011-03-31+6,000→ 24,101 total
Award
ONYX PHARMACEUTICALS INC
Common Stock
2011-03-31+22,500→ 46,601 total
Sale
ONYX PHARMACEUTICALS INC
Common Stock
2010-01-06$29.60/sh−1,919→ 11,581 total
Sale
ONYX PHARMACEUTICALS INC
Common Stock
2010-01-06$29.60/sh−1,919→ 11,581 total
Other
Jazz Pharmaceuticals plc$JAZZ
Common Stock
2008-05-30$6.50/sh+1,203→ 58,569 total
Other
Jazz Pharmaceuticals plc$JAZZ
Common Stock
2008-05-30$6.50/sh+1,203→ 58,569 total
Award
Jazz Pharmaceuticals plc$JAZZ
Option (right to buy)
2008-05-16+60,000→ 60,000 total
Award
Jazz Pharmaceuticals plc$JAZZ
Common Stock
2008-05-16+6,281→ 57,366 total
Award
Jazz Pharmaceuticals plc$JAZZ
Common Stock
2008-05-16+6,281→ 57,366 total
Award
Jazz Pharmaceuticals plc$JAZZ
Option (right to buy)
2008-05-16+60,000→ 60,000 total
Other
Jazz Pharmaceuticals plc$JAZZ
Common Stock
2007-11-30$13.18/sh+1,388→ 51,085 total
Other
Jazz Pharmaceuticals plc$JAZZ
Common Stock
2007-11-30$13.18/sh+1,388→ 51,085 total

Companies

Recent Filings

Address

C/O ATARA BIOTHERAPEUTICS, INC. 611 GATEWAY BOULEVARD, SUITE 900

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov